Search

Author/Creator Morand, Eric F

1. 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW). (14th December 2022)

Authors:
Morand, Eric F; Werth, Victoria P; Bender, Andrew; Deshpande, Aditee; Deshmukh, Ankita; Vaidyanathan, Bharat; Vazquez-Mateo, Cristina; Przetak, Melinda; Moreau, Flavie; Khursheed, Mukhy; Roy, Sanjeev; Pearson, David R
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 3
Page Start:
A93
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus. Issue 4 (21st April 2019)

Authors:
Vincent, Fabien B; Kandane‐Rathnayake, Rangi; Koelmeyer, Rachel; Hoi, Alberta Y; Harris, James; Mackay, Fabienne; Morand, Eric F
Journal:
Clinical & translational immunology
Issue:
Volume 8:Issue 4(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis. Issue 12 (6th December 2018)

Authors:
Vincent, Fabien B; Lin, Emily; Sahhar, Joanne; Ngian, Gene‐Siew; Kandane‐Rathnayake, Rangi; Mende, Rachel; Hoi, Alberta Y; Morand, Eric F; Lang, Tali; Harris, James
Journal:
Clinical & translational immunology
Issue:
Volume 7:Issue 12(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials. Issue 7 (25th March 2022)

Authors:
Vital, Edward M; Merrill, Joan T; Morand, Eric F; Furie, Richard A; Bruce, Ian N; Tanaka, Yoshiya; Manzi, Susan; Kalunian, Kenneth C; Kalyani, Rubana N; Streicher, Katie; Abreu, Gabriel; Tummala, Raj
Journal:
Annals of the rheumatic diseases
Issue:
Volume 81:Issue 7(2022)
Page Start:
951
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Issue 2 (24th November 2012)

Authors:
Vincent, Fabien B; Morand, Eric F; Murphy, Kim; Mackay, Fabienne; Mariette, Xavier; Marcelli, Christian
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Issue 2(2013)
Page Start:
165
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study. (December 2022)

Authors:
Connelly, Kathryn; Kandane-Rathnayake, Rangi; Hoi, Alberta; Louthrenoo, Worawit; Hamijoyo, Laniyati; Cho, Jiacai; Lateef, Aisha; Fen Luo, Shue; Wu, Yeong-Jian J; Li, Zhanguo; Navarra, Sandra; Zamora, Leonid; Sockalingam, Sargunan; Hao, Yanjie; Zhang, Zhuoli; Katsumata, Yasuhiro; Harigai, Masayosh...
Journal:
Lancet
Issue:
Volume 4:Number 12(2022)
Page Start:
e831
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗